WellRX Acquires Bioreach

November 27, 2024

WellRX, the parent company of ReviveRX and Ways2Well, has acquired Bioreach, a bloodwork and genetics laboratory, to bring advanced diagnostic capabilities in-house. The acquisition is intended to speed testing turnaround, enable deeper diagnostic integration across WellRX’s telehealth, pharmacy and preventative-care offerings, and support scaled delivery of advanced tests to partner clinics and patients nationwide.

Buyers
WellRX
Targets
Bioreach
Location
Utah, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.